Diagnosis and Treatment of Myelodysplastic Syndromes

医学 骨髓增生异常综合症 中性粒细胞减少症 内科学 入射(几何) 贫血 国际预后积分系统 髓系白血病 白血病 骨髓 儿科 化疗 光学 物理
作者
Mikkael A. Sekeres,Justin Taylor
出处
期刊:JAMA [American Medical Association]
卷期号:328 (9): 872-872 被引量:224
标识
DOI:10.1001/jama.2022.14578
摘要

Importance: Myelodysplastic neoplasms (MDS), formerly known as myelodysplastic syndromes, are clonal hematopoietic malignancies that cause morphologic bone marrow dysplasia along with anemia, neutropenia, or thrombocytopenia. MDS are associated with an increased risk of acute myeloid leukemia (AML). The yearly incidence of MDS is approximately 4 per 100 000 people in the United States and is higher among patients with advanced age. Observations: MDS are characterized by reduced numbers of peripheral blood cells, an increased risk of acute myeloid leukemia transformation, and reduced survival. The median age at diagnosis is approximately 70 years, and the yearly incidence rate increases to 25 per 100 000 in people aged 65 years and older. Risk factors associated with MDS include older age and prior exposures to toxins such as chemotherapy or radiation therapy. MDS are more common in men compared with women (with yearly incidence rates of approximately 5.4 vs 2.9 per 100 000). MDS typically has an insidious presentation, consisting of signs and symptoms associated with anemia, thrombocytopenia, and neutropenia. MDS can be categorized into subtypes that are associated with lower or higher risk for acute myeloid leukemia transformation and that help with therapy selection. Patients with lower-risk MDS have a median survival of approximately 3 to 10 years, whereas patients with higher-risk disease have a median survival of less than 3 years. Therapy for lower-risk MDS is selected based on whether the primary clinical characteristic is anemia, thrombocytopenia, or neutropenia. Management focuses on treating symptoms and reducing the number of required transfusions in patients with low-risk disease. For patients with lower-risk MDS, erythropoiesis stimulating agents, such as recombinant humanized erythropoietin or the longer-acting erythropoietin, darbepoetin alfa, can improve anemia in 15% to 40% of patients for a median of 8 to 23 months. For those with higher-risk MDS, hypomethylating agents such as azacitidine, decitabine, or decitabine/cedazuridine are first-line therapy. Hematopoietic cell transplantation is considered for higher-risk patients and represents the only potential cure. Conclusions and Relevance: MDS are diagnosed in approximately 4 per 100 000 people in the United States and are associated with a 5-year survival rate of approximately 37%. Treatments are tailored to the patient's disease characteristics and comorbidities and range from supportive care with or without erythropoiesis-stimulating agents for patients with low-risk MDS to hypomethylating agents, such as azacitidine or decitabine, for patients with higher-risk MDS. Hematopoietic cell transplantation is potentially curative and should be considered for patients with higher-risk MDS at the time of diagnosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Goxan完成签到,获得积分10
刚刚
xinyang发布了新的文献求助10
刚刚
if的应助被流年采纳,获得10
1秒前
风华发布了新的文献求助30
1秒前
房东的猫完成签到,获得积分10
1秒前
okok发布了新的文献求助10
1秒前
大模型的应助被zz采纳,获得10
2秒前
王紫晴给王紫晴的求助进行了留言
2秒前
LI完成签到,获得积分10
3秒前
彭于晏的应助被远方采纳,获得10
3秒前
3秒前
4秒前
4秒前
细腻裙子完成签到,获得积分10
4秒前
4秒前
深情安青的应助被虞山小王子采纳,获得10
5秒前
李里完成签到,获得积分20
5秒前
能干储完成签到,获得积分10
5秒前
梁晓宇完成签到,获得积分10
6秒前
情怀的应助被wyyyy采纳,获得10
6秒前
奔跑的应助被likun采纳,获得40
7秒前
7秒前
TranYan完成签到,获得积分10
7秒前
8秒前
9秒前
9秒前
刘华珍完成签到,获得积分10
10秒前
10秒前
小巧惜芹完成签到 ,获得积分10
11秒前
gas发布了新的文献求助10
11秒前
wangzhenghua完成签到 ,获得积分10
11秒前
温珩完成签到,获得积分10
11秒前
12秒前
nnn发布了新的文献求助10
12秒前
木今完成签到,获得积分10
12秒前
ding的应助被gxgxnn采纳,获得10
13秒前
13秒前
liu发布了新的文献求助10
13秒前
无物发布了新的文献求助10
14秒前
duoduo完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182147
求助须知:如何正确求助?哪些是违规求助? 9571790
关于积分的说明 21820037
捐赠科研通 7778601
什么是DOI,文献DOI怎么找? 3433617
关于科研通互助平台的介绍 2557786
邀请新用户注册赠送积分活动 2479652